11

Development of Thermoresponsive Diclofenac Ophthalmic In Situ Gels Formulaitons

By

Rathapon Asasutjarit, Ph.D.Department of Pharmaceutical Technology,

Faculty of Pharmacy, Rangsit University

Asira Fuongfuchat, Ph.D.National Metal and Materials Technology center,

National Science and Technology Development Agency (NSTDA)

22

Outline

1. Introduction

2. Objectives

3. Methods

4. Results and discussion

5. Conclusions

6. Acknowledgements

33

Introduction- Eye drop solution: convenient to use by instilling into conjunctival sac of the eye with accurate dose.

- Bioavailability is very poor: blinking reflex and lacrimal secretion.

- Inserts, ointments and suspensions.

Eye drop solution Insert Ointment

44

- In situ gels: pH, specific ion and temperature

- The thermoresponsive in situ gel is an in situ gel system responding to a shift in temperature.

- It is liquid at low temperature and becomes gel when in contact with higher temperature.

temperature

temperature

55

- Diclofenac is one of non-steroidal anti-inflammatory drugs approved for ocular use.

- Diclofenac is available in the drug market as an eye drop solution. It has been used intensively in the case of post-op inflammatory with 3-4 times of administration.

- Thus, minimized frequency of administration, once or twice daily, is necessary for increasing patient compliance.

66

- My previous work (Asasutjarit, 2008):

- Formulation of thermoresponsive diclofenac ophthalmic in situ gels

contained either

: Pluronic F127 (Poloxamer 407) or

: Combination of Pluronic F127 and hydroxypropylmethylcellulose

- Phase transition temperatures were lower than room temperature.

77

Objectives

The purposes of this study were to develop and to evaluate the formulation of thermoresponsive diclofenac ophthalmic in situ gels possessing optimum phase transition temperature.

88

1. Preparation of thermoresponsive diclofenac ophthalmic gels and products evaluation

: 0.1% w/w diclofenac sodium ophthalmic gels containing various gelling agent contents

: prepared on a weight basis by the cold method

Formulation (Rx)Gelling agent (%w/w)

F127 F68 Carbopol 940

1. F127-20 20 0 0

2. F127-20+F68-8 20 8 0

3. F127-20+F68-11 20 11 0

4. F127-20+F68-11+C.1

20 11 0.1

5. F127-20+F68-11+C.3

20 11 0.3

6. F127-20+F68-11+C.5

20 11 0.5

Methods, Results and discussion

99

: Phosphate buffer pH 7.4 was used in the formulations as vehicle except for the formulations containing carbopol 940, phosphate buffer pH 5.5 was used.

: All samples were analyzed spectrophotometrically for the content uniformity at a wavelength of 276 nm.

: Only samples with diclofenac sodium content within 100± 10% of labeled amount were accepted.

: They were measured their pH in triplicate by using a pH meter.

1010

2. Determination of phase behavior and sol-gel transition temperature of thermoresponsive

gels

2.1 Test tube inverting method : 2±1°C (storage temperature) : 27±1°C (room temperature) : 35±1°C (ophthalmic temperature).

1111

2.2 Temperature sweep test : Rheometer

- storage modulus (G´) and loss modulus (G´´) at varied temperatures

Semi logarithmic plot of storge modolus and tan delta againts temperature of F127-20 + F68-8(mean+SD)

0.001

0.1

10

1000

100000

0 5 10 15 20 25 30 35 40 45 50Temperature oc

G' G''

0.0010.010.11101001000100001000001000000

Tan delta

G' G'' Tan deltaGel phase

Sol phase

Phase transition

1212

Formulation (Rx)%Labeled amount

*Flow ability at various

temperatures Sol-gel transition

temperature (°C)

pH2±1 (°C)

27±1 (°C)

35±1 (°C)

1. F127-20 103.2±1.0 +++ - - 20.7±0.1 7.4±0.1

2. F127-20+F68-8 103.3±1.2 +++ + - 27.2±0.3 7.3±0.1

3. F127-20+F68-11 102.6±0.6 +++ +++ - 31.6±1.8 7.4±0.1

4. F127-20+F68-11+C.1

103.2±0.8 +++ +++ - 32.7±1.1 5.4±0.1

5. F127-20+F68-11+C.3

103.3±0.9 +++ +++ - 31.7±0.5 4.8±0.1

6. F127-20+F68-11+C.5

103.2±1.0 +++ +++ - 36.3±1.4 4.7±0.1

(n=3, mean± SD), *Flow ability: +++ = very good; ++ = good; + = flow; - = not flow

Preparation and evaluation of thermoresponsive diclofenac ophthalmic gels (continued)

1313

3. Gelling capacity test

Drop 20-μl of samples

A test tube containing 2-ml of simulated tear fluid (STF) (pH 7.4) equilibrated at 35 °C.

The visual assessment of gel formation and dissolution was performed in triplicate (Wu et al., 2007).

1414

Formulation (Rx)Time for remaining gel in

STF (min)

3. F127-20+F68-11 20.2±0.8

4. F127-20+F68-11+C.1*

40.4±0.7

5. F127-20+F68-11+C.2 45.3±0.6

6. F127-20+F68-11+C.3 49.0±0.4- The formulations containing carbopol 940 were eroded by STF more slowly than the formulation without carbopol 940 markedly.

- This is probably that carbopol 940 consisting in the formulations led to more stiff gel when pH of the environment was increased.

- Since formulation Rx 4. (F127-20+F68-11+C.1) had an optimum sol-gel transition temperature, pH and gelling capacity, it was chosen as a representative for the further experiments.

1515

4. Steady shear sweep test: The experiment was carried out at 27±1 °C and 35±1 °C by a rheometer for determination of flow behavior of Rx 4. (F127-

20+F68- 11+C.1)

: The initial and final shear rates were 0.05 and 100 s-1, respectively.

1616

0

200

400

600

800

1000

1200

0 10 20 30 40 50 60 70 80 90 100 110 120shear rate (s-1)

shear s

tress (Pa)

35 °C

27 °CPseudoplastic flow

Rheogram of Rx 4. (F127-20+F68-11+C.1)

1717

1.E-021.E-011.E+001.E+011.E+021.E+031.E+041.E+051.E+061.E+07

1E-03 1E-02 1E-01 1E+00 1E+01 1E+02 1E+03shear rate (s-1)

viscosity (

Pas)

35 °C

27 °C

- Ocular shear rate is about 0.03 s-1 during interblinking and 4,250- 28,000 s-1 during blinking.

Viscosity profile of Rx 4. (F127-20+F68-11+C.1)

1818

5. Eye irritation test : 4-New Zealand white rabbit

20-µl of the sample was instilled into the conjunctival sac of rabbit’s right eye

The left was kept as a control without manipulation.

0, 5, 10, 30 min, 1, 6, 12, 24, 48 and 72 hours

1919

Lesions Grades

Cornea

No ulceration or opacity 0

Scattered or diffuse areas of opacity (other than slight dulling of normal luster), details of iris clearly visible

1

Easily discernible translucent area, details of iris slightly obscured 2

Nacreous area, no details or iris visible, size of pupil barely discernible

3

Complete corneal opacity, iris not discernible 4

Iris

Normal 0

Markedly deepened folds, congestion, swelling, moderate circumcorneal injection,(any o these separately or combined) iris still reacting to light (sluggish reaction is positive)

1

No reaction to light, hemorrhage, gross destruction(any or all of these)

2(DiPasquale and Hayes, 2001)

2020

Lesions Grades

Conjunctive

Redness (refers to palpebral and bulbar conjunctivae, excluding cornea and iris)

Vessels normal 0

Some blood vessels definitely hyperemic (injected) 1

Diffuse, crimson color, individual vessels not easily discernible 2

Diffuse beefy red 3

Chemosis

No swelling 0

Any swelling above normal (includes nictitating membranes) 1

Obvious swelling with partial eversion of lids 2

Swelling with lids about half closed 3

Swelling with lids more than half-closed 4

(DiPasquale and Hayes, 2001)

2121

Lesions Grades

Cornea

No ulceration or opacity 0

Iris

Normal 0

Conjunctive

Vessels normal 0

Chemosis

No swelling 0

a

b

a: the test eye

b: the controlled eye

Results of eye irritation test of Rx 4. (F127-20+F68-11+C.1)

2222

6. Diclofenac absorption in the eye

- 8-New Zealand white rabbit Group 1 : Rx 4. (F127-20-+F68-11+C.1) Group 2 : Diclofenac eye drop solution (Original)

- Sampling time: 5, 10, 30 min, 1, 6, and 12 hours,

- Sampling volume: 200 µl

- Zoletil 100® im

- High-performance liquid chromatrography (HPLC)

2323

0

500

1,000

1,500

2,000

2,500

3,000

3,500

4,000

4,500

0 60 120 180 240 300 360 420 480 540 600 660 720

Time (min)

Eye drop solution

Thermoresponsive in situ gel

Concentra

tion o

f dicl

ofenac s

odium

in ra

bbit'

s aqu

eous hu

mor (ng

/ml)

Cmax gel = 3,900 ng/ml Rx 4. (F127-20+F68-11+C.1)

Cmax solution = 1,517 ng/mlDiclofenac eye drop solution (Original)

Diclofenac concentrations in aqueous humor

2424

Conclusions

- 20% w/w pluronic F127, 11% w/w pluronic F68 and 0.1% w/w carbopol 940.

- Exhibited solution character predominantly at the storage temperature and room temperature and became gel at the ophthalmic temperature.

- Sol-gel transition temperature was 32.7±1.1 °C.

- It was convenient to use without keeping in a refrigerator.

- It did not cause eye irritation in rabbits.

- It increased concentration of diclofenac in aqueous humor and prolonged the contact time of diclofenac in the eye.

- This formulation had a potential for the further study in patients suffering from inflamed eye.

2525

Acknowledgements

The authors gratefully acknowledge

- Mr. Chanwit Kammat, - Mr. Thumrongrat Pukpinyo, - Ms. Watunya Witisil, - Ms. Suthira Thansanchokpibull- Ms. Susiri Preedasuttichit

- Ass. Prof. Aree Thayananuphat, DVM, Ph.D.

- Research Institute, Rangsit University for the research grant No. 33/50.

2626

Thank you